Form 4: Astera Labs Exec Sells Shares Under 10b5-1 Plan

Astera Labs General Counsel and Secretary, Philip Mazzara, reported the sale of company stock totaling over 10,000 shares through a pre-arranged trading plan.

Summary

• Philip Mazzara, General Counsel and Secretary of Astera Labs, Inc., reported the sale of common stock on April 1, 2026.
• The sales were executed automatically under a Rule 10b5-1 trading plan adopted on May 29, 2025.
• A total of 10,015 shares were sold across multiple transactions at weighted average prices ranging from $105.86 to $111.01.
• Following these transactions, Mazzara beneficially owns 118,084 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sales were conducted under a pre-established Rule 10b5-1 plan, indicating a planned divestment rather than a reaction to negative company news.

Negatives

• Insider selling, even under a pre-arranged plan, can sometimes be perceived negatively by the market.

Risks

• The sales were conducted under a Rule 10b5-1 plan, which is designed to mitigate insider trading concerns, but the act of selling by a key executive could still be interpreted as a lack of confidence by some investors.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Industry Context

StockSavvy.ai notes that insider sales under Rule 10b5-1 plans are common for executives to diversify holdings or manage personal finances. While these plans are designed to avoid perceptions of insider trading, the volume and timing of such sales can still influence investor sentiment, especially for growth-oriented technology companies like Astera Labs.

Stakeholder Impact

• Shareholders: May interpret insider selling, even under a plan, as a potential signal, though the Rule 10b5-1 nature mitigates this concern.
• Employees: Similar to shareholders, the impact is likely minimal given the planned nature of the sales.
• Management: Reinforces the existence and use of established governance procedures for stock transactions.

Key Dates

Keywords

Astera Labs, ALAB, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Philip Mazzara, Beneficial Ownership, Securities Exchange Act